Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · IEX Real-Time Price · USD

3.390

-0.390 (-10.32%)

At close: Jul 2, 2024, 4:00 PM

3.580

+0.190 (5.60%)

After-hours: Jul 2, 2024, 5:20 PM EDT

Elicio Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-35.2	-28.21	-54.57	-80.11	-40.66	Upgrade
Depreciation & Amortization	1.17	1.06	0.8	0.63	0.5	Upgrade
Share-Based Compensation	1.18	0.58	12.04	4.72	3.34	Upgrade
Other Operating Activities	0.15	4.39	-10.91	51.88	12.24	Upgrade
Operating Cash Flow	-32.69	-22.18	-52.64	-22.89	-24.59	Upgrade
Capital Expenditures	-0.03	-0.65	-0.38	-0.04	-0.24	Upgrade
Investing Cash Flow	-0.03	-0.65	-0.38	-0.04	-0.24	Upgrade
Share Issuance / Repurchase	6.98	0.08	108.48	-0.48	-0.29	Upgrade
Debt Issued / Paid	10	0	0.29	32.12	5.27	Upgrade
Other Financing Activities	21.64	21.12	-1.6	20.77	-0.09	Upgrade
Financing Cash Flow	38.61	21.2	107.17	52.41	4.89	Upgrade
Exchange Rate Effect	0	0	0	-0.44	0	Upgrade
Net Cash Flow	5.89	-1.63	54.15	29.04	-19.94	Upgrade
Free Cash Flow	-32.73	-22.83	-53.03	-22.93	-24.83	Upgrade
Free Cash Flow Margin	-	-	-187.29%	-796.15%	-1669.87%	Upgrade
Free Cash Flow Per Share	-6.47	-72.26	-18.77	-15.53	-17.20	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).